Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
Century Therapeutics
IPSC
$302M
| $10.3M | ﹤0.01% |
4,194,981
-472,082
| -10% | -$1.08M |
2025 Q2
4 quarters
|
|
2177
Steel Dynamics
STLD
$34.1B
| $10.3M | ﹤0.01% |
44,724
+39,304
| +725% | +$9.21M |
2013 Q2
52 quarters
|
|
2178
Aeva Technologies
AEVA
$662M
| $10.2M | ﹤0.01% |
355,843
-875,519
| -71% | -$17.2M |
2025 Q3
3 quarters
|
|
2179
Victoria's Secret
VSXY
$8.69B
| $10.2M | ﹤0.01% |
122,381
-32,063
| -21% | -$1.92M |
2021 Q3
19 quarters
|
|
2180
World Acceptance Corp
WRLD
$751M
| $10.2M | ﹤0.01% |
45,588
-47,098
| -51% | -$7.57M |
2025 Q3
3 quarters
|
|
2181
PUT
LyondellBasell Industries
LYB
$20.4B
| $10.2M | ﹤0.01% |
193,700
+32,400
| +20% | +$2.24M |
2021 Q1
21 quarters
|
|
2182
PUT
Credo Technology Group
CRDO
$25.7B
| $10.2M | ﹤0.01% |
37,500
+34,500
| +1,150% | +$6.82M |
2025 Q1
5 quarters
|
|
2183
AngioDynamics
ANGO
$515M
| $10.2M | ﹤0.01% |
783,125
+138,448
| +21% | +$1.58M |
2020 Q2
24 quarters
|
|
2184
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.1B
| $10.2M | ﹤0.01% |
+128,764
| New | +$10.2M |
2026 Q2
0 quarters
|
|
2185
Fluor
FLR
$6.37B
| $10.2M | ﹤0.01% |
194,185
-112,488
| -37% | -$5.51M |
2016 Q1
41 quarters
|
|
2186
vTv Therapeutics
VTVT
$95M
| $10.2M | ﹤0.01% |
269,874
+63,586
| +31% | +$2.2M |
2026 Q1
1 quarter
|
|
2187
Crane Co
CR
$11.9B
| $10.1M | ﹤0.01% |
45,490
-438,925
| -91% | -$82.7M |
2023 Q2
12 quarters
|
|
2188
Par Pacific Holdings
PARR
$3.49B
| $10.1M | ﹤0.01% |
180,815
-305,396
| -63% | -$18.2M |
2020 Q4
22 quarters
|
|
2189
PUT
Canadian Natural Resources
CNQ
$102B
| $10.1M | ﹤0.01% |
204,100
+54,000
| +36% | +$2.45M |
2022 Q4
14 quarters
|
|
2190
Arteris
AIP
$890M
| $10.1M | ﹤0.01% |
208,522
+125,302
| +151% | +$4.01M |
2023 Q2
12 quarters
|
|
2191
Allogene Therapeutics
ALLO
$411M
| $10.1M | ﹤0.01% |
4,843,889
+1,521,836
| +46% | +$3.34M |
2025 Q1
5 quarters
|
|
2192
Altimmune
ALT
$412M
| $10.1M | ﹤0.01% |
3,309,122
+50,931
| +2% | +$152K |
2021 Q3
19 quarters
|
|
2193
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$944M
| $10.1M | ﹤0.01% |
4,431,031
+614,093
| +16% | +$1.15M |
2022 Q1
17 quarters
|
|
2194
Omega Healthcare
OHI
$14.9B
| $10.1M | ﹤0.01% |
210,942
-85,162
| -29% | -$3.95M |
2021 Q3
19 quarters
|
|
2195
WaterBridge Infrastructure LLC
WBI
$1.44B
| $10M | ﹤0.01% |
292,882
-280,626
| -49% | -$8.17M |
2025 Q3
3 quarters
|
|
2196
Brixmor Property Group
BRX
$9.28B
| $10M | ﹤0.01% |
318,245
-234,258
| -42% | -$7.15M |
2021 Q1
21 quarters
|
|
2197
Boyd Group Services
BGSI
$2.51B
| $10M | ﹤0.01% |
106,043
-46,858
| -31% | -$5.14M |
2025 Q4
2 quarters
|
|
2198
CALL
GSK
GSK
$102B
| $10M | ﹤0.01% |
191,100
-286,700
| -60% | -$15.2M |
2021 Q3
19 quarters
|
|
2199
BBB Foods
TBBB
$7.85B
| $10M | ﹤0.01% |
240,356
+67,699
| +39% | +$2.58M |
2024 Q1
9 quarters
|
|
|
ISNRU
2200
Snow Rothschild Acquisition Corp Units
ISNRU
| $10M | ﹤0.01% |
+1,000,000
| New | +$10M |
2026 Q2
0 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.